Control Bionics Ltd Total Liabilities
Control Bionics Ltd total liabilities. Based on the latest financial reports, Control Bionics Ltd (CBL) has total liabilities worth AU$2.73 Million AUD (≈ $1.93 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CBL cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Control Bionics Ltd (2014–2025)
Total liabilities of Control Bionics Ltd from 2014 to 2025. This chart illustrates how Control Bionics Ltd's total liabilities have evolved over time, based on quarterly financial data.
Control Bionics Ltd Competitors by Total Liabilities
The table below lists competitors of Control Bionics Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Prakit Holdings Public Company Limited
BK:PRAKIT
|
Thailand | ฿357.83 Million |
|
Ordinary Fully Paid Deferred Settlement
AU:88EDA
|
Australia | AU$356.79K |
|
Bannari Amman Spinning Mills Limited
NSE:BASML
|
India | Rs-4.74 Billion |
|
SANUWAVE Health, Inc. Common Stock
NASDAQ:SNWV
|
USA | $35.26 Million |
|
Catenon S.A
MC:COM
|
Spain | €2.60 Million |
|
Murudeshwar Ceramics Limited
NSE:MURUDCERA
|
India | Rs2.36 Billion |
|
PERFORMANCE SHIPP.
F:DS2
|
Germany | €236.42 Million |
|
Lipidor Ab
ST:LIPI
|
Sweden | Skr3.86 Million |
Liability Composition Analysis (2014–2025)
This chart breaks down Control Bionics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Control Bionics Ltd assets under control.
Liquidity & Leverage Metrics
Control Bionics Ltd Total Liabilities Ratios Explained
Control Bionics Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.54 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Control Bionics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Control Bionics Ltd (2014–2025)
The table below shows the annual total liabilities of Control Bionics Ltd from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | AU$2.73 Million ≈ $1.93 Million |
+0.38% |
| 2024-12-31 | AU$2.72 Million ≈ $1.93 Million |
-1.28% |
| 2023-12-31 | AU$2.76 Million ≈ $1.95 Million |
+74.65% |
| 2022-12-31 | AU$1.58 Million ≈ $1.12 Million |
+4.47% |
| 2021-12-31 | AU$1.51 Million ≈ $1.07 Million |
+27.07% |
| 2020-12-31 | AU$1.19 Million ≈ $842.14K |
+207.54% |
| 2019-12-31 | AU$387.00K ≈ $273.83K |
+2.98% |
| 2018-12-31 | AU$375.80K ≈ $265.90K |
+74.08% |
| 2017-12-31 | AU$215.88K ≈ $152.75K |
-99.98% |
| 2016-12-31 | AU$876.38 Million ≈ $620.10 Million |
+69.81% |
| 2015-12-31 | AU$516.09 Million ≈ $365.17 Million |
+19.03% |
| 2014-12-31 | AU$433.58 Million ≈ $306.78 Million |
-- |
About Control Bionics Ltd
Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally. It offers NeuroNode Trilogy, NeuroNode Duo, and Eye-gaze Duo systems that allow people with speech and movement difficulties to control a computer for speech generation, electroni… Read more